G. Kam

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy

R. Larson, M. Baccarani, D. Marin, 2010, Leukemia.

Clinical phenotype and prognosis of JAK 2 and CALR mutation in Asian patients with Essential Thrombocythemia

E. Koay, W. Chng, Y. Chee, 2018 .

JAK2 mutations in Asian patients with essential thrombocythaemia

E. Koay, G. Wong, G. Kam, 2011, Internal medicine journal.

Angioimmunoblastic T‐cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta‐analysis of 56 cases

E. Koay, T. P. Loh, D. Tan, 2012, Histopathology.

Surgery‐associated acquired haemophilia and response to combined rituximab and cyclosporine treatment

H. Ng, Y. Lee, T. T. Tan, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy

G. Wong, Ai Leen Ang, Y. Loh, 2015, Supportive Care in Cancer.

Stem cell transplantation programme at Singapore General Hospital

C. Chuah, W. Hwang, H. Ng, 2008, Bone Marrow Transplantation.

Azacitidine Causes Prolonged Neutropenia in an Elderly Patient with Primary Myelofibrosis Transformed To Acute Myeloid Leukemia

G. Kam, R. Yiu, 2012 .

Relationship between atypical T- and B-cell size predicts survival in peripheral T-cell lymphomas with large B-cells

T. P. Loh, D. Tan, S. Lim, 2013, Pathology.